Serial noninvasive assessment of apoptosis during right ventricular disease progression in rats

Journal of Nuclear Medicine

Volumn 50, Issue 8, 2009, Pages 1371-1377

  Campian, Maria E ^a   Verberne, Hein J ^b   Hardziyenka, Maxim ^a   De Bruin, Kora ^b   Selwaness, Mariana ^a   Van Den Hoff, Maurice J B ^a   Ruijter, Jan M ^a   Van Eck Smit, Berthe L F ^b   De Bakker, Jacques M T ^a   Tan, Hanno L ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Annexin; Apoptosis; Fibrosis; Heart failure; Hypertrophy; Right ventricle

Indexed keywords

LIPOCORTIN 5; LIPOCORTIN 5 TECHNETIUM TC99M; MONOCROTALINE; TECHNETIUM 99M; UNCLASSIFIED DRUG; VALSARTAN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART RIGHT VENTRICLE FAILURE; HEART SCINTISCANNING; NICK END LABELING; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

ANIMALS; ANNEXIN A5; APOPTOSIS; DISEASE PROGRESSION; MALE; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 68249150556     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.061366     Document Type: Article

References (41)

1. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117:1717-1731.
2. Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114: 1883-1891.
3. Bleasdale RA, Frenneaux MP. Prognostic importance of right ventricular dysfunction. Heart. 2002;88:323-324.
4. Abbate A, Scarpa S, Santini D, et al. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure: an experimental study in the spontaneously hypertensive rat. Int J Cardiol. 2005;111:371-376.
5. Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184-192.
6. Berenji K, Drazner MH, Rothermel A, Hill JA. Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol. 2005;289:H8-H16.
7. Anversa P, Leri A, Beltrami CA, Guerra S, Kajstura J. Myocyte death and growth in the failing heart. Lab Invest. 1998;78:767-786.
8. Weber KT. Targeting pathophysiological remodeling: concepts of cardioprotection and reparation. Circulation. 2000;102:1342-1345.
9. Sabbah HN, Stein PD, Kono T, et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol. 1991;260:H1379-H1384.
10. Schaper J, Froede R, Hein S, et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991; 83:504-514.
11. Ecarnot-Laubriet A, Assem M, Poirson-Bichat F, et al. Stage-dependent activation of cell cycle and apoptosis mechanisms in the right ventricle by pressure overload. Biochim Biophys Acta. 2002;1586:233-242.
12. Ikeda S, Hamada M, Hiwada K. Cardiomyocyte apoptosis with enhanced expression of P53 and Bax in right ventricle after pulmonary arterial banding. Life Sci. 1999;65:925-933.
13. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA. 1998;95:6349-6354.
14. Kato T, Nasu T, Sonoda H, Ito KM, Ikeda M, Ito K. Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension. J Cardiovasc Pharmacol. 2008;51:18-23.
15. Cigola E, Kajstura J, Li B, Meggs LG, Anversa P. Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res. 1997;231:363-371.
16. Li D, Tomson K, Yang B, Mehta P, Croker BP, Mehta JL. Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: role of AT1 receptor activation. Cardiovasc Res. 1999;41: 109-115.
17. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 1996.
18. Lalich JJ, Merkow L. Pulmonary arteritis produced in rats by feeding: Crotolaria spectabilis. Lab Invest. 1961;10:744-750.
19. Hardziyenka M, Campian ME, de Bruin-Bon RHACM, Michel MC, Tan HL. Sequence of echocardiographic changes during development of right ventricular failure in rat. J Am Soc Echocardiogr. 2006;19:1272-1279.
20. Habraken JBA, de Bruin K, Shehata M, et al. Evaluation of high-resolution pinhole SPECT using a small rotating animal. J Nucl Med. 2001;42:1863-1869.
21. Knol RJJ, de Bruin K de Jong J, van Eck-Smit BLF, Booij J. In vitro and ex vivo storage phosphor imaging of short-living radioisotopes. J Neurosci Methods. 2008;168:341-357.
22. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
23. Burke AP, Farb A, Tashko G, Virmani R. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium. Circulation. 1998;97:1571-1580.
24. Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000;356:209-212.
25. Vriens P, Blankenberg F, Stoot J, et al. The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg. 1998;11:844-853.
26. Hofstra L, Dumont EA, Thimister PW, et al. In vivo detection of apoptosis in an intracardiac tumor. JAMA. 2001;285:1841-1842.
27. 99mTc-labeled annexin A5 in heart failure. J Nucl Med. 2007;48:562-567.
28. Narula J, Strauss HWPS. P.S.* I love you: implications of phosphatidyl serine (PS) reversal in acute ischemic syndromes. J Nucl Med. 2003;44:397-399.
29. 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis. Eur J Nucl Med Mol Imaging. 2003;30:232-238.
30. Cassis LA, Rippetoe PE, Soltis EE, Painter DJ, Fitz R, Gillespie MN. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist. J Pharmacol Exp Ther. 1992;262:1168-1172.
31. Kreutz R, Fernandez-Alfonso MS, Ganten D, Paul M. Effect of losartan on right ventricular hypertrophy and cardiac angiotensin I-converting enzyme activity in pulmonary hypertensive rats. Clin Exp Hypertens. 1996;18:101-111.
32. Cohn JN, Tagnoni G. Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667-1675.
33. Krum H, Casson P, Farsang C, et al. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT. Eur J Heart Fail. 2004;6:937-945.
34. Leri A, Liu Y, Claudio PP, et al. Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis. Am J Pathol. 1999;154:567-580.
35. Li D, Yang B, Phillip MI, Metha JL. Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation. Am J Physiol. 1999;276:H786-H792.
36. 1 attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 rat. Hypertension. 2000;36:747-754.
37. Sun Y, Ramires FJ, Zhou G, Ganjam VK, Weber KT. Fibrous tissue and angiotensin II. J Mol Cell Cardiol. 1997;29:2001-2012.
38. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing heart. N Engl J Med. 1997;336:1131-1141.
39. Wencker D, Chandra M, Nguyen K, et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest. 2003;111:1497-1504.
40. Kostin S, Pool L, Elsässer A, et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res. 2003;92:715-724.
41. Laufer EM, Reutelingsperger CPM, Narula J, Hofstra L. Annexin A5: an imaging biomarker of cardiovascular risk. Basic Res Cardiol. 2008;103:95-104.